Market Overview

Benzinga's Top Upgrades, Downgrades For September 1, 2020

Share:

Upgrades

  • For Qualcomm Inc (NASDAQ: QCOM), Wells Fargo upgraded the previous rating of Underweight to the current rating Equal-Weight. For the third quarter, Qualcomm had an EPS of $0.86, compared to year-ago quarter EPS of $0.80. At the moment, the stock has a 52-week-high of $121.06 and a 52-week-low of $58.00. Qualcomm closed at $119.10 at the end of the last trading period.
  • B. Riley FBR upgraded the previous rating for NeoPhotonics Corp (NYSE: NPTN) from Neutral to Buy. In the second quarter, NeoPhotonics showed an EPS of $0.16, compared to $0.03 from the year-ago quarter. The stock has a 52-week-high of $10.34 and a 52-week-low of $4.65. At the end of the last trading period, NeoPhotonics closed at $6.67.
  • For Bloomin Brands Inc (NASDAQ: BLMN), Raymond James upgraded the previous rating of Outperform to the current rating Strong Buy. Bloomin Brands earned $0.74 in the second quarter, compared to $0.36 in the year-ago quarter. The stock has a 52-week-high of $24.29 and a 52-week-low of $4.54. At the end of the last trading period, Bloomin Brands closed at $14.34.
  • Morgan Stanley upgraded the previous rating for Novartis AG (NYSE: NVS) from Equal-Weight to Overweight. In the second quarter, Novartis showed an EPS of $1.36, compared to $1.34 from the year-ago quarter. The stock has a 52-week-high of $99.84 and a 52-week-low of $69.18. At the end of the last trading period, Novartis closed at $86.05.
  • BTIG upgraded the previous rating for Zoom Video Communications Inc (NASDAQ: ZM) from Neutral to Buy. In the second quarter, Zoom Video Communications showed an EPS of $0.92, compared to $0.08 from the year-ago quarter. At the moment, the stock has a 52-week-high of $325.90 and a 52-week-low of $60.97. Zoom Video Communications closed at $325.10 at the end of the last trading period.
  • For CNO Financial Group Inc (NYSE: CNO), Piper Sandler upgraded the previous rating of Neutral to the current rating Overweight. For the second quarter, CNO Finl Gr had an EPS of $0.55, compared to year-ago quarter EPS of $0.48. The current stock performance of CNO Finl Gr shows a 52-week-high of $20.93 and a 52-week-low of $8.79. Moreover, at the end of the last trading period, the closing price was at $16.32.
  • Morgan Stanley upgraded the previous rating for Spire Inc (NYSE: SR) from Underweight to Equal-Weight. Spire earned $0.07 in the third quarter, compared to $0.07 in the year-ago quarter. The current stock performance of Spire shows a 52-week-high of $88.00 and a 52-week-low of $56.97. Moreover, at the end of the last trading period, the closing price was at $58.25.
  • For Zoom Video Communications Inc (NASDAQ: ZM), Goldman Sachs upgraded the previous rating of Sell to the current rating Neutral. Zoom Video Communications earned $0.92 in the second quarter, compared to $0.08 in the year-ago quarter. At the moment, the stock has a 52-week-high of $325.90 and a 52-week-low of $60.97. Zoom Video Communications closed at $325.10 at the end of the last trading period.
  • Piper Sandler upgraded the previous rating for Zendesk Inc (NYSE: ZEN) from Neutral to Overweight. For the second quarter, Zendesk had an EPS of $0.14, compared to year-ago quarter EPS of $0.05. The stock has a 52-week-high of $101.94 and a 52-week-low of $50.23. At the end of the last trading period, Zendesk closed at $96.38.
  • KeyBanc upgraded the previous rating for Extra Space Storage Inc (NYSE: EXR) from Underweight to Sector Weight. Extra Space Storage earned $1.23 in the second quarter, compared to $1.22 in the year-ago quarter. At the moment, the stock has a 52-week-high of $124.45 and a 52-week-low of $72.70. Extra Space Storage closed at $106.63 at the end of the last trading period.

 

Downgrades

  • Needham downgraded the previous rating for Rosetta Stone Inc (NYSE: RST) from Buy to Hold. In the second quarter, Rosetta Stone showed an EPS of $0.15, compared to $0.12 from the year-ago quarter. The current stock performance of Rosetta Stone shows a 52-week-high of $31.24 and a 52-week-low of $8.85. Moreover, at the end of the last trading period, the closing price was at $30.38.
  • For Brinker International Inc (NYSE: EAT), Raymond James downgraded the previous rating of Outperform to the current rating Market Perform. In the fourth quarter, Brinker International showed an EPS of $0.88, compared to $1.36 from the year-ago quarter. The stock has a 52-week-high of $47.57 and a 52-week-low of $7.00. At the end of the last trading period, Brinker International closed at $45.04.
  • According to Raymond James, the prior rating for Darden Restaurants Inc (NYSE: DRI) was changed from Strong Buy to Outperform. Darden Restaurants earned $1.24 in the fourth quarter, compared to $1.76 in the year-ago quarter. The stock has a 52-week-high of $128.41 and a 52-week-low of $26.15. At the end of the last trading period, Darden Restaurants closed at $86.60.
  • According to BMO Capital, the prior rating for Akcea Therapeutics Inc (NASDAQ: AKCA) was changed from Outperform to Market Perform. Akcea Therapeutics earned $0.49 in the second quarter, compared to $0.40 in the year-ago quarter. The stock has a 52-week-high of $22.79 and a 52-week-low of $8.00. At the end of the last trading period, Akcea Therapeutics closed at $18.28.
  • Cantor Fitzgerald downgraded the previous rating for Aimmune Therapeutics Inc (NASDAQ: AIMT) from Overweight to Neutral. For the second quarter, Aimmune Therapeutics had an EPS of $1.06, compared to year-ago quarter EPS of $1.01. The stock has a 52-week-high of $37.00 and a 52-week-low of $10.09. At the end of the last trading period, Aimmune Therapeutics closed at $34.22.
  • Oppenheimer downgraded the previous rating for Acasti Pharma Inc (NASDAQ: ACST) from Outperform to Perform. Acasti Pharma earned $0.05 in the first quarter, compared to $0.15 in the year-ago quarter. The current stock performance of Acasti Pharma shows a 52-week-high of $3.08 and a 52-week-low of $0.23. Moreover, at the end of the last trading period, the closing price was at $0.24.

 

Initiations

  • With a current rating of Buy, Truist Securities initiated coverage on Murphy Oil Corp (NYSE: MUR). The price target seems to have been set at $22.00 for Murphy Oil. In the second quarter, Murphy Oil showed an EPS of $0.71, compared to $0.21 from the year-ago quarter. The stock has a 52-week-high of $28.12 and a 52-week-low of $4.50. At the end of the last trading period, Murphy Oil closed at $13.74.
  • Morgan Stanley initiated coverage on Motorola Solutions Inc (NYSE: MSI) with an Overweight rating. The price target for Motorola Solutions is set to $28.00. Motorola Solutions earned $1.39 in the second quarter, compared to $1.69 in the year-ago quarter. The current stock performance of Motorola Solutions shows a 52-week-high of $187.49 and a 52-week-low of $120.77. Moreover, at the end of the last trading period, the closing price was at $154.91.
  • With a current rating of Outperform, SVB Leerink initiated coverage on CytoSorbents Corp (NASDAQ: CTSO). The price target seems to have been set at $15.00 for CytoSorbents. In the second quarter, CytoSorbents showed an EPS of $0.08, compared to $0.11 from the year-ago quarter. The stock has a 52-week-high of $11.74 and a 52-week-low of $3.49. At the end of the last trading period, CytoSorbents closed at $8.44.
  • Baird initiated coverage on WillScot Mobile Mini Holdings Corp (NASDAQ: WSC) with a Neutral rating. The price target for WillScot Mobile Mini is set to $21.00. WillScot Mobile Mini earned $0.10 in the second quarter, compared to $0.04 in the year-ago quarter. The stock has a 52-week-high of $19.79 and a 52-week-low of $7.45. At the end of the last trading period, WillScot Mobile Mini closed at $17.90.
  • With a current rating of Buy, Citigroup initiated coverage on IBEX Holdings Ltd (NASDAQ: IBEX). The price target seems to have been set at $22.00 for IBEX Holdings. The stock has a 52-week-high of $18.00 and a 52-week-low of $14.66. At the end of the last trading period, IBEX Holdings closed at $15.99.
  • With a current rating of Buy, Jefferies initiated coverage on Checkmate Pharmaceuticals Inc (NASDAQ: CMPI). The price target seems to have been set at $22.00 for Checkmate Pharmaceuticals. Checkmate Pharmaceuticals closed at $15.58 at the end of the last trading period.
  • With a current rating of Buy, BTIG initiated coverage on INmune Bio Inc (NASDAQ: INMB). The price target seems to have been set at $23.00 for INmune Bio. In the second quarter, INmune Bio showed an EPS of $0.20, compared to $0.04 from the year-ago quarter. The current stock performance of INmune Bio shows a 52-week-high of $24.42 and a 52-week-low of $2.20. Moreover, at the end of the last trading period, the closing price was at $10.50.
  • With a current rating of Buy, DA Davidson initiated coverage on CarParts.com Inc (NASDAQ: PRTS). The price target seems to have been set at $19.00 for CarParts.com. CarParts.com earned $0.03 in the second quarter, compared to $0.04 in the year-ago quarter. The current stock performance of CarParts.com shows a 52-week-high of $16.44 and a 52-week-low of $1.04. Moreover, at the end of the last trading period, the closing price was at $14.05.
  • JP Morgan initiated coverage on Freeline Therapeutics Holdings PLC (NASDAQ: FRLN) with an Overweight rating. The price target for Freeline Therapeutics is set to $27.00. Moreover, at the end of the last trading period, the closing price was at $16.11.
  • JP Morgan initiated coverage on TG Therapeutics Inc (NASDAQ: TGTX) with an Overweight rating. The price target for TG Therapeutics is set to $38.00. TG Therapeutics earned $0.47 in the second quarter, compared to $0.42 in the year-ago quarter. The stock has a 52-week-high of $25.02 and a 52-week-low of $4.95. At the end of the last trading period, TG Therapeutics closed at $24.80.
  • RBC Capital initiated coverage on IBEX Holdings Ltd (NASDAQ: IBEX) with an Outperform rating. The price target for IBEX Holdings is set to $23.00. At the moment, the stock has a 52-week-high of $18.00 and a 52-week-low of $14.66. IBEX Holdings closed at $15.99 at the end of the last trading period.
  • Goldman Sachs initiated coverage on Glu Mobile Inc (NASDAQ: GLUU) with a Buy rating. The price target for Glu Mobile is set to $9.80. In the second quarter, Glu Mobile showed an EPS of $0.05, compared to $0.02 from the year-ago quarter. At the moment, the stock has a 52-week-high of $10.85 and a 52-week-low of $3.98. Glu Mobile closed at $7.94 at the end of the last trading period.
  • With a current rating of Buy, Stifel initiated coverage on Apellis Pharmaceuticals Inc (NASDAQ: APLS). The price target seems to have been set at $40.00 for Apellis Pharmaceuticals. For the second quarter, Apellis Pharmaceuticals had an EPS of $1.57, compared to year-ago quarter EPS of $1.12. The stock has a 52-week-high of $45.04 and a 52-week-low of $16.85. At the end of the last trading period, Apellis Pharmaceuticals closed at $30.83.
 

Related Articles (ACST + AIMT)

View Comments and Join the Discussion!

Posted-In: Initiations top upgradesPenny Stocks Upgrades Downgrades Initiation Intraday Update Analyst Ratings

Latest Ratings

StockFirmActionPT
MSFTStifelMaintains245.0
TXRHJP MorganMaintains67.0
SBUXJP MorganMaintains82.0
MCDJP MorganMaintains220.0
CMGJP MorganMaintains1,115.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com